Answers are grounded in this paper and cite their sources.
receptor, enhance serotonergic activity, or block the activity of noradrenaline at β receptors. The results also have implications for prescribers to consider sleepwalking as a potential adverse effect and ensure that: 1) the patient is educated about a safe sleep environment; 2) they are encouraged to report the onset or exacerbation of sleepwalking, and 3) alternative treatments are considered if sleepwalking occurs.
No takes yet. Share an insight, caveat, or question.
Stallman et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: